Correlation Between Moderna and Novavax
Can any of the company-specific risk be diversified away by investing in both Moderna and Novavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moderna and Novavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moderna and Novavax, you can compare the effects of market volatilities on Moderna and Novavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moderna with a short position of Novavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moderna and Novavax.
Diversification Opportunities for Moderna and Novavax
Good diversification
The 3 months correlation between Moderna and Novavax is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Moderna and Novavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novavax and Moderna is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moderna are associated (or correlated) with Novavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novavax has no effect on the direction of Moderna i.e., Moderna and Novavax go up and down completely randomly.
Pair Corralation between Moderna and Novavax
Given the investment horizon of 90 days Moderna is expected to under-perform the Novavax. But the stock apears to be less risky and, when comparing its historical volatility, Moderna is 1.39 times less risky than Novavax. The stock trades about -0.05 of its potential returns per unit of risk. The Novavax is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 709.00 in Novavax on June 11, 2025 and sell it today you would earn a total of 87.00 from holding Novavax or generate 12.27% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Moderna vs. Novavax
Performance |
Timeline |
Moderna |
Novavax |
Moderna and Novavax Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Moderna and Novavax
The main advantage of trading using opposite Moderna and Novavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moderna position performs unexpectedly, Novavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novavax will offset losses from the drop in Novavax's long position.Moderna vs. BioNTech SE | Moderna vs. Novavax | Moderna vs. Ginkgo Bioworks Holdings | Moderna vs. Crispr Therapeutics AG |
Novavax vs. Moderna | Novavax vs. Inovio Pharmaceuticals | Novavax vs. BioNTech SE | Novavax vs. AstraZeneca PLC ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |